AstraZeneca Pharma India appoints Dr. Shashank Srinivasan as Medical Director – Oncology Business Unit, effective April 1, 2026.
Mr. Venkat Natarajan promoted to Director – Market Access Business Unit from Lead – Market Access, effective April 1, 2026.
Disclosure filed under Regulation 30 of SEBI LODR Regulations 2015, pursuant to SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.